argenx reports positive phase 3 ADAPT SERON results of VYVGART in AChR-Ab seronegative gMG
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The complex four-hour surgery was performed by a multidisciplinary team of doctors
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
The company is bringing precision therapies for gynaecological cancers
This project shall be implemented through incorporation of a new joint venture company in Zambia
Subscribe To Our Newsletter & Stay Updated